Calcium alpha-ketoglutarate and the longevity research

Ca-AKG is a molecule your cells already make. Mouse studies are interesting. Human data is early. Here is what we actually know.

TL;DR

• Ca-AKG is a calcium salt of alpha-ketoglutarate (AKG), a molecule the body produces naturally in the Krebs cycle — the cell’s energy-production cycle.
• A 2020 Cell Metabolism study found AKG extended median lifespan about 12% in female mice. That is animal data, not human proof.
• Human evidence is early and limited. A 2021 analysis of 42 people reported lower biological age scores, but it had no control group.

What calcium alpha-ketoglutarate is

Ca-AKG is a calcium salt form of alpha-ketoglutarate. Your cells make AKG every day inside the Krebs cycle — the cell’s energy-production cycle. Think of the Krebs cycle as a factory floor. AKG is one part on the assembly line. Ca-AKG is a supplement form that delivers AKG alongside calcium. Both are compounds the body already recognizes.

How Ca-AKG works

AKG plays several roles inside the cell. It feeds into energy production. It also acts as a cofactor for enzymes involved in gene expression. Here is the analogy. Think of your cell as a power plant. AKG is both a fuel source and a dial on the control panel. Researchers believe this dual role may connect AKG to aging pathways. That is the hypothesis. The evidence is still early.

Who asks about Ca-AKG

People researching longevity supplements often find Ca-AKG on lists alongside NAD+ and spermidine. It comes up most for people in their 40s and 50s. They want to understand the science before spending money on a new supplement.

What the research says

In 2020, researchers at the Salk Institute published a study in Cell Metabolism. They reported AKG extended median lifespan about 12% in female mice and reduced frailty markers. Those are animal results, not human results.

In 2021, a small retrospective analysis published in Aging (Albany NY) followed 42 adults taking a Ca-AKG formulation called Rejuvant®. Researchers reported an average reduction in DNA-methylation biological age scores. DNA methylation is an epigenetic marker — a chemical tag on your DNA. Scientists use patterns in these tags to estimate biological age. The study had no control group and no blinding. That limits what the data can tell us.

No large randomized controlled trials in humans have been completed yet.

What to know

Ca-AKG is generally well tolerated in reported studies. Dose ranges studied in humans have been around 1,000 mg daily. Side effects reported were mild and gastrointestinal. None of that means the supplement is right for everyone. “Well tolerated in a 42-person open-label study” is not a safety stamp.

The Halftime POV

We find the Ca-AKG research interesting. We are not ready to call it conclusive. The mouse data is compelling on its own terms. The human data is early and preliminary. If you are curious about longevity compounds, this one is worth watching. It is not yet a settled answer. A physician should be part of any decision about adding new supplements to a routine.

Related reading:

• The hallmarks of aging, explained
• Healthspan vs. lifespan: what’s the difference?
• Autophagy: what it is and why it matters
• Longevity evidence vs. hype: how to read the research
• NAD+ mechanism: how it works in the body

FAQ

What is calcium alpha-ketoglutarate?

Calcium alpha-ketoglutarate (Ca-AKG) is a calcium salt of alpha-ketoglutarate (AKG), a molecule your body already produces in the Krebs cycle — the cell’s energy-production cycle. It is sold as a supplement and has drawn attention from researchers studying aging.

Does alpha-ketoglutarate extend lifespan?

In mice, a 2020 Cell Metabolism study reported AKG extended median lifespan about 12% in females and reduced frailty. That is animal data. Human evidence is limited to a small 2021 retrospective study with no control group. No large human trials have been completed.

Is calcium alpha-ketoglutarate safe?

A 42-person open-label study reported only mild, gastrointestinal side effects. That is a very small sample. Ca-AKG has not been tested in large randomized trials. Anyone considering it should discuss it with their physician first.

Disclaimer

This article is educational and is not medical advice. Compounded medications are not FDA-approved. Clinical outcomes depend on individual factors and require physician evaluation. Results vary. Halftime Health is launching soon — join the waitlist to get updates.

Get updates

Halftime Health is launching soon. We’ll share what we learn along the way — the research, the regulations, the real-world trade-offs. Join the waitlist and we’ll email you when we’re live.

Sources

• https://pubmed.ncbi.nlm.nih.gov/32877686/
• https://pmc.ncbi.nlm.nih.gov/articles/PMC8660611/